Matches in SemOpenAlex for { <https://semopenalex.org/work/W2168412437> ?p ?o ?g. }
- W2168412437 endingPage "636" @default.
- W2168412437 startingPage "625" @default.
- W2168412437 abstract "Background: Conditionally replicating adenoviruses (CRAds) can be engineered to replicate selectively in cancer cells and cause cancer-specific cell lysis; thus they are considered a promising cancer therapy. Methods: To elucidate the mechanisms by which CRAds induce cancer-specific cell death, we infected normal human fibroblasts (MRC5, telomerase negative), human malignant glioma (U373-MG and U87-MG), human cervical cancer (HeLa), and human prostate cancer (PC3) cells (all telomerase positive) with CRAds regulated by the human telomerase reverse transcriptase promoter (hTERT-Ad) or control nonreplicating adenoviruses (Ad-GFP). Nonapoptotic autophagy was assessed in Ad-GFP- and hTERT-Ad–infected cells by examining cell morphology, the development of acidic vesicular organelles, and the conversion of microtubule-associated protein 1 light chain 3 from the cytoplasmic form to the autophagosome membrane form; signaling via mammalian target of rapamycin (mTOR), an autophagy-associated molecule, was monitored by western blot analysis. We also compared the growth of subcutaneous gliomas in nude mice that were treated by intratumoral injection with Ad-GFP or hTERT-Ad. Survival of athymic mice carrying intracranial gliomas treated by intratumoral injection with Ad-GFP or hTERT-Ad was compared by using the Kaplan–Meier method and the Cox–Mantel log-rank analysis. All statistical tests were two-sided. Results: hTERT-Ad induced tumor-specific autophagic cell death in tumor cells and in subcutaneous gliomas. hTERT-Ad–induced autophagy was associated with hTERT-Ad infection kinetics. The mTOR signaling pathway was suppressed in tumor cells and in subcutaneous gliomas treated with hTERT-Ad compared with GFP-Ad or no treatment as shown by reduced phosphorylation of mTOR's downstream target p70S6 kinase (p70S6K). hTERT-Ad treatment of mice (n = 7) slowed growth of subcutaneous gliomas (mean tumor volume = 39 mm 3 , 95% confidence interval [CI] = 23 to 54 mm 3 ) compared with GFP-Ad treatment (n = 7) (mean tumor volume = 200 mm 3 , 95% CI = 149 to 251 mm 3 ) at day 7 (volume difference = 161 mm 3 , 95% CI = 126 to 197 mm 3 ; P <.001). Mice carrying intracranial tumors that were treated with three intratumoral injections of hTERT-Ad survived longer (53 days) than after treatment with GFP-Ad (29 days) (seven mice per group, difference = 24 days, 95% CI = 20 to 28 days; P <.001). Conclusions: hTERT-Ad may kill telomerase-positive cancer cells by inducing autophagic cell death." @default.
- W2168412437 created "2016-06-24" @default.
- W2168412437 creator A5000931343 @default.
- W2168412437 creator A5002464755 @default.
- W2168412437 creator A5005194857 @default.
- W2168412437 creator A5016395681 @default.
- W2168412437 creator A5026241338 @default.
- W2168412437 creator A5033476836 @default.
- W2168412437 creator A5037426292 @default.
- W2168412437 creator A5047515302 @default.
- W2168412437 creator A5061032146 @default.
- W2168412437 creator A5069293782 @default.
- W2168412437 creator A5075177015 @default.
- W2168412437 creator A5081345866 @default.
- W2168412437 creator A5091806633 @default.
- W2168412437 date "2006-05-03" @default.
- W2168412437 modified "2023-10-03" @default.
- W2168412437 title "Autophagic Cell Death of Malignant Glioma Cells Induced by a Conditionally Replicating Adenovirus" @default.
- W2168412437 cites W1544229812 @default.
- W2168412437 cites W1558969188 @default.
- W2168412437 cites W1784425676 @default.
- W2168412437 cites W1968008033 @default.
- W2168412437 cites W1970212185 @default.
- W2168412437 cites W1972582451 @default.
- W2168412437 cites W1987644026 @default.
- W2168412437 cites W1989113088 @default.
- W2168412437 cites W1993643473 @default.
- W2168412437 cites W199447113 @default.
- W2168412437 cites W2000208656 @default.
- W2168412437 cites W2001467419 @default.
- W2168412437 cites W2003852184 @default.
- W2168412437 cites W2005142336 @default.
- W2168412437 cites W2012451546 @default.
- W2168412437 cites W2016040396 @default.
- W2168412437 cites W2016647287 @default.
- W2168412437 cites W2020222773 @default.
- W2168412437 cites W2022386076 @default.
- W2168412437 cites W2022957248 @default.
- W2168412437 cites W2028627047 @default.
- W2168412437 cites W2033494613 @default.
- W2168412437 cites W2034172998 @default.
- W2168412437 cites W2051758487 @default.
- W2168412437 cites W2057382033 @default.
- W2168412437 cites W2057764483 @default.
- W2168412437 cites W2062960997 @default.
- W2168412437 cites W2064661688 @default.
- W2168412437 cites W2066800765 @default.
- W2168412437 cites W2072581924 @default.
- W2168412437 cites W2073134590 @default.
- W2168412437 cites W2073947345 @default.
- W2168412437 cites W2090794460 @default.
- W2168412437 cites W2092999710 @default.
- W2168412437 cites W2100495176 @default.
- W2168412437 cites W2104381422 @default.
- W2168412437 cites W2106989835 @default.
- W2168412437 cites W2108086395 @default.
- W2168412437 cites W2108967610 @default.
- W2168412437 cites W2111109862 @default.
- W2168412437 cites W2115886998 @default.
- W2168412437 cites W2117210608 @default.
- W2168412437 cites W2126224474 @default.
- W2168412437 cites W2128023051 @default.
- W2168412437 cites W2129308939 @default.
- W2168412437 cites W2142297099 @default.
- W2168412437 cites W2155043438 @default.
- W2168412437 cites W2157778451 @default.
- W2168412437 cites W2161234475 @default.
- W2168412437 cites W2324529925 @default.
- W2168412437 cites W2328197645 @default.
- W2168412437 cites W4293241248 @default.
- W2168412437 doi "https://doi.org/10.1093/jnci/djj161" @default.
- W2168412437 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16670388" @default.
- W2168412437 hasPublicationYear "2006" @default.
- W2168412437 type Work @default.
- W2168412437 sameAs 2168412437 @default.
- W2168412437 citedByCount "157" @default.
- W2168412437 countsByYear W21684124372012 @default.
- W2168412437 countsByYear W21684124372013 @default.
- W2168412437 countsByYear W21684124372014 @default.
- W2168412437 countsByYear W21684124372015 @default.
- W2168412437 countsByYear W21684124372016 @default.
- W2168412437 countsByYear W21684124372017 @default.
- W2168412437 countsByYear W21684124372018 @default.
- W2168412437 countsByYear W21684124372019 @default.
- W2168412437 countsByYear W21684124372020 @default.
- W2168412437 countsByYear W21684124372021 @default.
- W2168412437 countsByYear W21684124372022 @default.
- W2168412437 countsByYear W21684124372023 @default.
- W2168412437 crossrefType "journal-article" @default.
- W2168412437 hasAuthorship W2168412437A5000931343 @default.
- W2168412437 hasAuthorship W2168412437A5002464755 @default.
- W2168412437 hasAuthorship W2168412437A5005194857 @default.
- W2168412437 hasAuthorship W2168412437A5016395681 @default.
- W2168412437 hasAuthorship W2168412437A5026241338 @default.
- W2168412437 hasAuthorship W2168412437A5033476836 @default.
- W2168412437 hasAuthorship W2168412437A5037426292 @default.
- W2168412437 hasAuthorship W2168412437A5047515302 @default.
- W2168412437 hasAuthorship W2168412437A5061032146 @default.